ArticleImmunity, inflammation and disease2026
Predictive Role of Serum Inflammatory Markers in Metastatic Luminal A/B Breast Cancers Receiving CDK-4/6 Inhibitors Therapy.
Nilufer Bulut et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.